Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 47
Filter
1.
Hum Pathol ; 139: 1-8, 2023 09.
Article in English | MEDLINE | ID: mdl-37364824

ABSTRACT

Anecdotal evidence suggests that pancreatic acinar metaplasia (PAM) and intestinal metaplasia (IM) overlap infrequently at the gastroesophageal junction/distal esophagus (GEJ/DE). The goal of this study was to evaluate the significance of PAM at GEJ/DE in relation to IM in patients with gastroesophageal reflux disease (GERD). Group 1 comprised 230 consecutive patients with GEJ/DE biopsies (80.6% with GERD symptoms). Group 2 comprised 151 patients with established GERD and GEJ/DE biopsies taken before Nissen fundoplication. Group 3 comprised 540 consecutive patients used for a follow-up study of PAM. PAM was present in 15.7%-15.9% and IM in 24.8%-31.1% of patients in groups 1 and 2, respectively. PAM-IM overlap was present in 2.2%-3.3%, respectively. Patients with PAM were, on average, 6-12 years younger than patients with IM, and were predominantly female (72.2%-75%), in contrast to patients with IM (47.3%-32%). In the unadjusted logistic regression model, patients with PAM were 69%-65% less likely to also have IM, as compared to patients without PAM. In the fully adjusted model, patients with PAM were 35%-61% less likely to also have IM, although the P-value was not significant. Follow-up analysis of patients with PAM from group 3 (n = 28) demonstrated the prevalence of IM and PAM in subsequent biopsies at 7.1% and 60.7%, respectively. No cases showed PAM-IM overlap on follow-up. The data suggests that PAM at the GEJ/DE is associated with protective effect against IM and thus could be useful as a marker of decreased susceptibility to IM.


Subject(s)
Barrett Esophagus , Gastroesophageal Reflux , Humans , Female , Male , Follow-Up Studies , Gastroesophageal Reflux/pathology , Esophagogastric Junction/pathology , Metaplasia/pathology , Barrett Esophagus/pathology
2.
Mod Pathol ; 36(5): 100128, 2023 05.
Article in English | MEDLINE | ID: mdl-36889057

ABSTRACT

The assessment of the expression of programmed cell death ligand-1 (PD-L1) using immunohistochemistry (IHC) has been controversial since its introduction. The methods of assessment and the range of assays and platforms contribute to confusion. Perhaps the most challenging aspect of PD-L1 IHC is the combined positive score (CPS) method of interpretation of IHC results. Although the CPS method is prescribed for more indications than any other PD-L1 scoring system, its reproducibility has never been rigorously assessed. In this study, we collected a series of 108 gastric or gastroesophageal junction cancer cases, stained them using the Food and Drug Administration-approved 22C3 assay, scanned them, and then circulated them to 14 pathologists at 13 institutions for the assessment of interpretative concordance for the CPS system. We found that higher cut points (10 or 20) performed better than a CPS of <1 or >1. We used the Observers Needed to Evaluate Subjective Tests algorithm to assess how the CPS system might perform in the real-world setting and found that the cut points of <1 or >1 showed an overall percent agreement of only 30% among the pathologist raters, with a plateau occurring at 8 raters. The raters performed better at higher cut points. However, the best cut point of <20 versus that of >20 was still disappointing, with a plateau at an overall percent agreement of 70% (at 7 raters). Although there is no ground truth for CPS, we compared the score with quantitative messenger RNA measurement and showed no relationship between the score (at any cut point) and messenger RNA amount. In summary, we showed that CPS shows high subjective variability among pathologist readers and is likely to perform poorly in the real-world setting. This system may be the root cause of the poor specificity and relatively low predictive value of IHC companion diagnostic tests for PD-1 axis therapies that use the CPS system.


Subject(s)
Esophageal Neoplasms , Stomach Neoplasms , Humans , Apoptosis , B7-H1 Antigen/metabolism , Biomarkers, Tumor/metabolism , Esophagogastric Junction/pathology , Immunohistochemistry , Ligands , Pathologists , Reproducibility of Results , Stomach Neoplasms/diagnosis
3.
Dis Esophagus ; 35(12)2022 Dec 14.
Article in English | MEDLINE | ID: mdl-35758407

ABSTRACT

Pathologic complete response (pCR) to neoadjuvant chemoradiation for locally advanced esophageal adenocarcinoma (EAC) confers significantly improved survival. The ability to infer pCR may spare esophagectomy in some patients. Currently, there are no validated biomarkers of pCR. This study sought to evaluate whether a distinct signature of DNA copy number alterations (CNA) can be predictive of pCR in EAC. Pretreatment biopsies from 38 patients with locally advanced EAC (19 with pCR and 19 with pathologic partial/poor response) were assessed for CNA using OncoScan assay. A novel technique was employed where within every cytogenetic band, the quantity of bases gained by each sample was computed as the sum of gained genomic segment lengths weighted by the surplus copy number of each segment. A threefold cross-validation was used to assess association with pCR or pathologic partial/poor response. Forty patients with locally advanced EAC from The Cancer Genome Atlas (TCGA) constituted an independent validation cohort. Gains in the chromosomal loci 14q11 and 17p11 were preferentially associated with pCR. Average area under the receiver operating characteristic curve (AUC) for predicting pCR was 0.80 among the threefold cross-validation test sets. Using 0.3 megabases as the cutoff that optimizes trade-off between sensitivity (63%) and specificity (89%) in the discovery cohort, similar prediction performance for clinical and radiographic response was demonstrated in the validation cohort from TCGA (sensitivity 61%, specificity 82%). Copy number gains in the 14q11 and 17p11 loci may be useful for prediction of pCR, and, potentially, personalization of esophagectomy in EAC.


Subject(s)
Adenocarcinoma , Esophageal Neoplasms , Humans , Treatment Outcome , Esophageal Neoplasms/therapy , Esophageal Neoplasms/drug therapy , Adenocarcinoma/genetics , Adenocarcinoma/therapy , Esophagectomy , Neoadjuvant Therapy/methods
4.
Am J Clin Pathol ; 156(2): 278-287, 2021 07 06.
Article in English | MEDLINE | ID: mdl-33609026

ABSTRACT

OBJECTIVES: Although histologic features in biopsies suggesting a possibility of achalasia would be helpful diagnostically, such features remain unknown. The goal of this study was to explore the prevalence, histologic features, and immunophenotype of lymphocytic esophagitis (LyE) in achalasia biopsies. METHODS: The study group consisted of 57 patients with achalasia. Controls comprised 52 patients with severe gastroesophageal reflux disease (GERD) and normal esophageal motility. CD4/CD8 immunophenotype of lymphocytes was analyzed by immunohistochemistry. RESULTS: LyE was identified in 30% (17/57) of patients with achalasia and 6% (3/52) of patients with GERD, indicating a strong association with achalasia (odds ratio, 6.94; 95% confidence interval, 1.90-25.38). LyE was focal in 59% (10/17) of the cases and diffuse in 41% (7/17). CD4 T-cell predominance over CD8 T cells was observed in 88% of patients with achalasia and LyE. T helper 1 (Th1) cells, but not T helper 2 cells, were expanded in CD4 T cells; in the absence of evident infection, this was compatible with the role of Th1 cells in organ-specific autoimmunity. CONCLUSIONS: Achalasia should be considered in the differential diagnosis of clinical entities associated with CD4-predominant LyE. Additional studies to explore the significance of Th1 cells in achalasia-associated LyE are warranted.


Subject(s)
Esophageal Achalasia/immunology , Esophageal Achalasia/pathology , Esophagitis/pathology , Th1 Cells/immunology , Adult , Aged , CD4-Positive T-Lymphocytes/immunology , Esophageal Achalasia/diagnosis , Esophagitis/epidemiology , Esophagitis/immunology , Female , Humans , Male , Middle Aged , Prevalence
5.
Diagn Cytopathol ; 49(2): E65-E70, 2021 Feb.
Article in English | MEDLINE | ID: mdl-32816379

ABSTRACT

Follicular dendritic cell sarcoma (FDCS) is a rare malignant neoplasm of follicular dendritic cell origin which can present a diagnostic challenge. Due to the rarity of this neoplasm, its molecular pathogenesis has not been fully elaborated. A previous series of 13 cases reported that 38% contained mutations of genes encoding proteins involved in negative regulation of NF-κB. NF-κB is a family of transcription factors regulated through multiple cellular processes known as the canonical and noncanonical pathways. Here we present the case of a 62-year-old man who presented with abdominal pain and systemic symptoms and was found to have a mass in the porta hepatis. Fine needle aspiration cytology demonstrated a spindle cell neoplasm with vesicular chromatin and prominent nucleoli with admixed lymphocytes. Surgical resection showed an intranodal, 7.3 × 5.5 × 3.5 cm, solid mass composed of plump, spindle to histiocytoid cells with ovoid nuclei and small, prominent nucleoli arranged in a whorled and fascicular pattern. The lesional cells stained positively for CD21, CD23, and CD35 by immunohistochemistry, consistent with a diagnosis of FDCS. Next-generation sequencing revealed pathologic mutations in three genes involved in NF-κB regulation pathways: NFKBIA, TNFAIP3, and TRAF3. A pathologic TP53 mutation was also identified. This case report supports prior associations of the NF-κB pathway dysregulation and FDCS. Additionally, it is the first reported FDCS case with TRAF3 mutation as well as the first reported case to suggest disruption in both the canonical and noncanonical NF-κB pathways in the same lesion.


Subject(s)
Dendritic Cell Sarcoma, Follicular/diagnosis , Dendritic Cell Sarcoma, Follicular/pathology , Intranuclear Space/pathology , Biopsy, Fine-Needle/methods , Dendritic Cell Sarcoma, Follicular/metabolism , Humans , Immunohistochemistry/methods , Male , Middle Aged , NF-kappa B/metabolism , Signal Transduction/physiology
6.
Diagn Cytopathol ; 49(3): E130-E136, 2021 Mar.
Article in English | MEDLINE | ID: mdl-32975903

ABSTRACT

Malignant gastrointestinal neuroectodermal tumor (GNET) is an extremely rare neoplasm. Immunohistochemically, GNET typically demonstrates neural differentiation but lacks melanocytic differentiation, making it distinct from clear cell sarcoma of the soft tissues (CCS). Herein we report for the first time the cytomorphologic features of lymph node metastasis from presumably liver GNET. A 36-year-old female presented with fevers, night sweats, loss of appetite, and a 20-lbs weight loss. Radiographic imaging showed a 13 cm heterogeneously enhancing mass in the right lobe of the liver and a hypermetabolic 0.9 cm periportal lymph node on positron emission tomography-computed tomography (PET/CT). Initially, a CT-guided liver biopsy was performed followed by right hepatic lobectomy and portal lymphadenectomy. The liver biopsy and resection showed an S100-protein and SOX10 positive malignant neoplasm and genomic profiling of liver biopsy revealed EWSR1-CREB1gene rearrangement. These findings in conjunction with the morphologic and immunohistochemical profile were diagnostic of GNET. Two months later, she presented with recurrent lymphadenopathy in the upper abdomen. Fine needle aspiration of the periportal nodal mass revealed single and clusters of primitive, large to medium-sized neoplastic cells with round to oval nuclei, high nuclear-cytoplasmic ratio, vesicular chromatin, and prominent nucleoli. The tumor cells were S100 protein and SOX10 positive, consistent with metastasis of the patient's recently diagnosed malignant digestive system GNET. Palliative chemotherapy was administered but the patient died a few days later, 4 months from the initial diagnosis. Awareness of this entity and judicial use of ancillary studies including molecular testing are essential for achieving accurate diagnosis.


Subject(s)
Digestive System Neoplasms/diagnosis , Digestive System Neoplasms/pathology , Digestive System/pathology , Lymphatic Metastasis/pathology , Neuroectodermal Tumors/diagnosis , Neuroectodermal Tumors/pathology , Adult , Biopsy, Fine-Needle/methods , Diagnosis, Differential , Female , Humans , Sarcoma, Clear Cell/diagnosis , Sarcoma, Clear Cell/pathology
7.
Arch Pathol Lab Med ; 145(9): 1138-1143, 2021 09 01.
Article in English | MEDLINE | ID: mdl-33373450

ABSTRACT

CONTEXT.­: Published reports have suggested an association of lymphocytic esophagitis (LyE) with gastroesophageal reflux disease (GERD) and primary motility disorders and have also shown that GERD and motility disorders frequently overlap. These findings make it difficult to determine the true relationship between LyE and GERD, which may be confounded by the presence of motility disorders with LyE. OBJECTIVE.­: To characterize patterns of lymphocytic inflammation in patients with GERD who have no motility abnormalities. DESIGN.­: We identified 161 patients seen at our institution from 1998 to 2014 who were diagnosed with GERD, had normal esophageal motility, and available esophageal biopsies. LyE was defined as peripapillary lymphocytosis with rare or absent granulocytes. CD4 and CD8 immunophenotype of lymphocytes was evaluated using immunohistochemistry. RESULTS.­: We found increased intraepithelial lymphocytes in 13.7% of patients with GERD. Two major patterns and 1 minor pattern of lymphocytic inflammation were observed as follows: (1) LyE (in 6.8% [11 of 161] of patients and typically focal), (2) dispersed lymphocytes in an area of reflux esophagitis (in 5.6% [9 of 161] and typically diffuse), and (3) peripapillary lymphocytes in an area of reflux esophagitis (in 1.2% [2 of 161]). CD8 T cells significantly outnumbered CD4 T cells in 91% of patients with lymphocytic esophagitis and 100% of patients with dispersed lymphocytes (9 of 9) or peripapillary lymphocytes (2 of 2) in the area of reflux esophagitis. CONCLUSIONS.­: These findings suggest that LyE is one of the major patterns of lymphocytic inflammation in GERD. CD8 T-cell-predominant immunophenotype may be useful as a marker of GERD in the differential diagnosis of LyE.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Esophagitis/immunology , Esophagitis/pathology , Gastroesophageal Reflux/immunology , Gastroesophageal Reflux/pathology , Adult , Aged , Female , Humans , Inflammation/immunology , Inflammation/pathology , Male , Middle Aged
8.
Mod Pathol ; 34(4): 808-822, 2021 04.
Article in English | MEDLINE | ID: mdl-33299110

ABSTRACT

Non-alcoholic steatohepatitis (NASH) is a fatty liver disease characterized by accumulation of fat in hepatocytes with concurrent inflammation and is associated with morbidity, cirrhosis and liver failure. After extraction of a liver core biopsy, tissue sections are stained with hematoxylin and eosin (H&E) to grade NASH activity, and stained with trichrome to stage fibrosis. Methods to computationally transform one stain into another on digital whole slide images (WSI) can lessen the need for additional physical staining besides H&E, reducing personnel, equipment, and time costs. Generative adversarial networks (GAN) have shown promise for virtual staining of tissue. We conducted a large-scale validation study of the viability of GANs for H&E to trichrome conversion on WSI (n = 574). Pathologists were largely unable to distinguish real images from virtual/synthetic images given a set of twelve Turing Tests. We report high correlation between staging of real and virtual stains ([Formula: see text]; 95% CI: 0.84-0.88). Stages assigned to both virtual and real stains correlated similarly with a number of clinical biomarkers and progression to End Stage Liver Disease (Hazard Ratio HR = 2.06, 95% CI: 1.36-3.12, p < 0.001 for real stains; HR = 2.02, 95% CI: 1.40-2.92, p < 0.001 for virtual stains). Our results demonstrate that virtual trichrome technologies may offer a software solution that can be employed in the clinical setting as a diagnostic decision aid.


Subject(s)
Azo Compounds , Coloring Agents , Eosine Yellowish-(YS) , Image Interpretation, Computer-Assisted , Liver Cirrhosis/diagnosis , Liver/pathology , Methyl Green , Microscopy , Neural Networks, Computer , Non-alcoholic Fatty Liver Disease/diagnosis , Staining and Labeling , Adolescent , Adult , Aged , Aged, 80 and over , Biopsy , Child , Clinical Decision-Making , Decision Support Techniques , Female , Hematoxylin , Humans , Liver Cirrhosis/pathology , Male , Middle Aged , Non-alcoholic Fatty Liver Disease/pathology , Predictive Value of Tests , Reproducibility of Results , Retrospective Studies , Severity of Illness Index , Software , Young Adult
9.
Ann N Y Acad Sci ; 1481(1): 5-10, 2020 12.
Article in English | MEDLINE | ID: mdl-32783223

ABSTRACT

A variety of inflammatory disorders involve the esophagus. This commentary discusses the pathology of some forms of esophagitis, with an emphasis on recent developments. The initial section focuses on some common forms of nonreflux esophagitis, including lymphocytic esophagitis and eosinophilic esophagitis. Recent studies suggest that lymphocytic esophagitis may be associated with esophageal motility disorders and gastroesophageal reflux disease. Immunophenotypic features of intraepithelial lymphocytes may be helpful in distinguishing these conditions. Updates on the criteria and the limitations of histologic approach to the diagnosis of eosinophilic esophagitis are presented and new diagnostic adjuncts are discussed. In the remaining section, novel entities, such as IgG4-related esophagitis, are discussed. IgG4-related esophagitis has been recognized as a cause of esophageal lymphoplasmacytic inflammation. Increased understanding of esophageal inflammation remains an important goal that likely will lead to new approaches in the therapy of inflammatory esophageal diseases.


Subject(s)
Eosinophilic Esophagitis/immunology , Esophageal Motility Disorders/immunology , Esophagus/immunology , Eosinophilic Esophagitis/pathology , Esophageal Motility Disorders/pathology , Esophagus/pathology , Humans , Immunoglobulin G/immunology , Inflammation/immunology , Inflammation/pathology , Lymphocytes/immunology , Lymphocytes/pathology
10.
JAMA Netw Open ; 3(4): e203398, 2020 04 01.
Article in English | MEDLINE | ID: mdl-32324237

ABSTRACT

Importance: Histologic classification of colorectal polyps plays a critical role in screening for colorectal cancer and care of affected patients. An accurate and automated algorithm for the classification of colorectal polyps on digitized histopathologic slides could benefit practitioners and patients. Objective: To evaluate the performance and generalizability of a deep neural network for colorectal polyp classification on histopathologic slide images using a multi-institutional data set. Design, Setting, and Participants: This prognostic study used histopathologic slides collected from January 1, 2016, to June 31, 2016, from Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, with 326 slides used for training, 157 slides for an internal data set, and 25 for a validation set. For the external data set, 238 slides for 179 distinct patients were obtained from 24 institutions across 13 US states. Data analysis was performed from April 9 to November 23, 2019. Main Outcomes and Measures: Accuracy, sensitivity, and specificity of the model to classify 4 major colorectal polyp types: tubular adenoma, tubulovillous or villous adenoma, hyperplastic polyp, and sessile serrated adenoma. Performance was compared with that of local pathologists' at the point of care identified from corresponding pathology laboratories. Results: For the internal evaluation on the 157 slides with ground truth labels from 5 pathologists, the deep neural network had a mean accuracy of 93.5% (95% CI, 89.6%-97.4%) compared with local pathologists' accuracy of 91.4% (95% CI, 87.0%-95.8%). On the external test set of 238 slides with ground truth labels from 5 pathologists, the deep neural network achieved an accuracy of 87.0% (95% CI, 82.7%-91.3%), which was comparable with local pathologists' accuracy of 86.6% (95% CI, 82.3%-90.9%). Conclusions and Relevance: The findings suggest that this model may assist pathologists by improving the diagnostic efficiency, reproducibility, and accuracy of colorectal cancer screenings.


Subject(s)
Colonic Polyps/diagnosis , Colonic Polyps/pathology , Image Interpretation, Computer-Assisted/methods , Neural Networks, Computer , Algorithms , Deep Learning , Histocytochemistry , Humans , Sensitivity and Specificity
11.
Curr Opin Gastroenterol ; 35(4): 379-386, 2019 07.
Article in English | MEDLINE | ID: mdl-33216485

ABSTRACT

PURPOSE OF REVIEW: A multitude of inflammatory diseases other than gastroesophageal reflux disease (GERD) and eosinophilic esophagitis can affect the esophagus. Despite the deceptively simple organization of squamous mucosa and its limited number of inflammatory responses, a wide array of histologic patterns can be seen in inflammatory disorders involving the esophagus. Each such histologic pattern is associated with a limited number of underlying conditions, and the clinician can use this information to narrow the differential diagnosis. The purpose of this review is to review and discuss the pathologic diagnosis of esophagitis caused by conditions other than GERD or eosinophilic esophagitis, with an emphasis on recent developments in the field. RECENT FINDINGS: Recent studies suggest that lymphocytic esophagitis may be a histologic manifestation of esophageal motility disorders. Immunophenotypic features of infiltrating lymphocytes may be helpful in this scenario. immunoglobulin G4-related disease has been implicated as a cause of esophageal inflammation with ulceration, strictures, and mass-forming fibrosis, whereas epidermoid metaplasia has been linked molecularly to the squamous cell neoplasia pathway. SUMMARY: Improved knowledge and appreciation of the pathology of esophageal inflammation are needed to better understand the pathogenesis of various types of esophagitis, and to inform new approaches to the therapy and management of inflammatory esophageal diseases.


Subject(s)
Eosinophilic Esophagitis , Esophageal Motility Disorders , Gastroesophageal Reflux , Eosinophilic Esophagitis/diagnosis , Gastroesophageal Reflux/complications , Gastroesophageal Reflux/diagnosis , Humans , Inflammation
12.
Mod Pathol ; 31(11): 1653-1660, 2018 11.
Article in English | MEDLINE | ID: mdl-29921901

ABSTRACT

The diagnosis of Candida esophagitis can be challenging when the epithelium containing Candida filamentous forms is not readily seen or is entirely sloughed away. Mucosal inflammation could be helpful diagnostically, if distinctive. However it is thought to be nonspecific in Candida esophagitis. The goal of this retrospective study was to identify features of mucosal inflammation helpful in alerting a pathologist to the possibility of Candida esophagitis when Candida mycelia are not readily observed. The study group consisted of 99 consecutive cases of Candida esophagitis and a control group of 64 consecutive cases of reflux esophagitis diagnosed at our institution from 2008-2016. Band-like superficial intraepithelial neutrophils and increased intraepithelial lymphocytes were observed in 75 and 67% of Candida esophagitis cases, respectively and only in 14 and 19% of reflux esophagitis cases, respectively (p < .0001). Intraepithelial lymphocytes were peripapillary or CD4-predominant in 75% of Candida esophagitis cases with increased lymphocytes, in contrast to 17% of reflux esophagitis cases (p = .0011). Concurrent presence of intraepithelial neutrophils and increased lymphocytes showed increased specificity for Candida esophagitis and was observed in 61% of patients with Candida esophagitis and only in 2% of patients with reflux esophagitis (p < .0001). In addition, superficial band-like neutrophils were observed concurrently with increased peripapillary lymphocytes or CD4-predominant lymphocytes in 35 and 50% of Candida esophagitis cases, respectively, in contrast to no reflux esophagitis cases. Basal cell hyperplasia and elongation of stromal papillae were frequent in both groups. The data suggest that when Candida microorganisms are not readily observed, concurrent presence of superficial band-like neutrophils and increased lymphocytes may be indicative of Candida etiology of active esophagitis.


Subject(s)
Candidiasis/diagnosis , Esophagitis/diagnosis , Esophagitis/microbiology , Inflammation/pathology , Mucous Membrane/pathology , Adult , Aged , Esophagitis/pathology , Female , Humans , Inflammation/microbiology , Male , Middle Aged , Mucous Membrane/microbiology , Neutrophils/pathology , Retrospective Studies
13.
Ann N Y Acad Sci ; 1434(1): 304-318, 2018 12.
Article in English | MEDLINE | ID: mdl-29761508

ABSTRACT

The esophagus, a straight tube that connects the pharynx to the stomach, has the complex architecture common to the rest of the gastrointestinal tract with special differences that relate to its function as a conduit of ingested substances. For instance, it has submucosal glands that are unique and have a specific protective function. It has a squamous lining that exists nowhere else in the gut except the anus and it has a different submucosal nerve plexus when compared to the stomach and intestines. All of the layers of the esophageal wall and the specialized structures including blood and lymphatic vessels and nerves have specific responses to injury. The esophagus also has unique features such as patches of gastric mucosa called inlet patches at the very proximal part and it has a special sphincter mechanism at the most distal aspect. This review covers the normal microscopic anatomy of the esophagus and the patterns of reaction to stress and injury of each layer and each special structure.


Subject(s)
Esophageal Mucosa , Esophagogastric Junction , Esophageal Mucosa/blood supply , Esophageal Mucosa/injuries , Esophageal Mucosa/innervation , Esophageal Mucosa/pathology , Esophagogastric Junction/blood supply , Esophagogastric Junction/injuries , Esophagogastric Junction/innervation , Esophagogastric Junction/pathology , Humans
14.
Ann N Y Acad Sci ; 1434(1): 219-226, 2018 12.
Article in English | MEDLINE | ID: mdl-29766506

ABSTRACT

Gastroenterologists frequently perform endoscopic esophageal mucosal biopsies for pathologic diagnosis in patients experiencing symptoms of esophagitis. The more common causes of esophagitis diagnosed on esophageal mucosal biopsy include reflux esophagitis, eosinophilic esophagitis, and infectious esophagitis caused by Candida albicans, herpes simplex virus, and/or cytomegalovirus. However, there are several causes of esophagitis seen less frequently by pathologists that are very important to recognize. We discuss unique types of esophageal inflammation, including acute bacterial esophagitis, esophageal manifestations of dermatologic diseases, medication-induced esophageal injury, and sloughing esophagitis; and we review their clinical and histopathologic features.


Subject(s)
Eosinophilic Esophagitis , Esophagitis, Peptic , Esophagus , Bacterial Infections/metabolism , Bacterial Infections/microbiology , Bacterial Infections/pathology , Bacterial Infections/virology , Biopsy , Candida albicans/metabolism , Candidiasis/metabolism , Candidiasis/microbiology , Candidiasis/virology , Cytomegalovirus/metabolism , Cytomegalovirus Infections/metabolism , Cytomegalovirus Infections/microbiology , Cytomegalovirus Infections/virology , Eosinophilic Esophagitis/metabolism , Eosinophilic Esophagitis/microbiology , Eosinophilic Esophagitis/pathology , Eosinophilic Esophagitis/virology , Esophagitis, Peptic/metabolism , Esophagitis, Peptic/microbiology , Esophagitis, Peptic/pathology , Esophagitis, Peptic/virology , Esophagoscopy , Esophagus/metabolism , Esophagus/microbiology , Esophagus/pathology , Esophagus/virology , Herpes Simplex/metabolism , Herpes Simplex/microbiology , Herpes Simplex/pathology , Herpes Simplex/virology , Humans , Inflammation/metabolism , Inflammation/microbiology , Inflammation/pathology , Inflammation/virology , Simplexvirus/metabolism
15.
Mod Pathol ; 31(6): 989-996, 2018 06.
Article in English | MEDLINE | ID: mdl-29422640

ABSTRACT

There is limited data on the spectrum of molecular alterations in goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids of the appendix. We used next generation sequencing to determine mutations of potential pathogenetic and therapeutic significance in this rare group of tumors. Adequate DNA was successfully extracted in 34/46 cases and the final group included 18 goblet cell carcinoids and 16 adenocarcinoma ex goblet cell carcinoids. Illumina TruSeq™ was used for sequencing exons of a custom 282 gene panel using an Illumina HiSeq 2000. All cases had a minimum coverage depth of at least 50 reads. After filtering through the Exome Sequencing Project, the number of mutations per case ranged from 0-9 (mean:3). The mutational burden in adenocarcinoma ex goblet cell carcinoids was significantly higher than goblet cell carcinoids (mean 5 vs. 3; p < 0.05) but the spectrum of alterations overlapped between the two groups. The most frequent mutations included ARID1A (4/34), ARID2 (4/34), CDH1 (4/34), RHPN2 (4/34), and MLL2 (3/34). Some mutations typically seen in conventional colorectal adenocarcinomas were also identified but with much lower frequency (APC :4/34; KRAS :2/34). MLL2 and KRAS mutations were only seen in adenocarcinoma ex goblet cell carcinoids and TP53 mutations were limited to poorly differentiated adenocarcinoma ex goblet cell carcinoids (2/34). Copy number changes could be evaluated in 15/34 cases and showed low copy number gains in CDKN1B (6/15) and NFKBIA (6/15), among others. The overlapping molecular alterations suggest that goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids are best considered two grades of differentiation of the same tumor rather than two distinct histological types. Mutations in TP53, CDH1 and MLL2 mutations were predominantly present in the adenocarcinoma ex goblet cell carcinoid group consistent with transformation to a higher grade lesion. The unique mutational profile also offers an explanation for the poor chemosensitivity in these tumors and highlights the need for developing new targeted therapies.


Subject(s)
Adenocarcinoma/genetics , Appendiceal Neoplasms/genetics , Carcinoid Tumor/genetics , Colorectal Neoplasms/genetics , Mutation , Adenocarcinoma/pathology , Adult , Aged , Appendiceal Neoplasms/pathology , Carcinoid Tumor/pathology , Colorectal Neoplasms/pathology , Female , Gene Expression Regulation, Neoplastic , Humans , Male , Middle Aged
16.
J Clin Gastroenterol ; 52(6): 524-529, 2018 07.
Article in English | MEDLINE | ID: mdl-28723863

ABSTRACT

BACKGROUND: Distinguishing sessile serrated adenomas/polyp (SSA/P), a subset of serrated polyps, from hyperplastic polyps (HPs) remains a challenge and has surveillance implications. Our goal was to identify clinical and pathologic factors associated with serrated polyps originally read as HPs being reassessed as SSA/Ps versus confirmed as HPs. METHODS: Data were collected from consecutive patients with a right-sided HP and a corresponding comparison group with conventional adenomas between 1993 and 2003. Two experienced gastrointestinal pathologists, blinded to polyp and clinical factors, reinterpreted the HPs using current SSA/P classification criteria. These HPs were classified as SSA/P when diagnostic histologic feature(s) were present in at least 3 crypts. Analyses, conducted on a per polyp basis, examined the factors associated with risk of individual HPs being reassessed as SSA/Ps as opposed to being confirmed as HPs. RESULTS: Of the 702 HPs (355 adults), 188 (26.8%) were reclassified as SSA/Ps. Predictors of HPs being reinterpreted as SSA/Ps included: size ≥5 mm [odds ratio (OR), 2.09; 95% confidence interval (CI), 1.34-3.26], proximal location (OR, 2.83; 95% CI, 1.69-4.74), synchronous adenomas with advanced pathology (OR, 2.61; 95% CI, 1.22-5.55) and ≥1 synchronous HPs (other than HP being reassessed) reclassified as SSA/Ps (OR, 11.76; 95% CI, 6.75-20.49). CONCLUSIONS: Because HP versus SSP is not very reproducible the predictors of SSA/P that we identified, including size, location, and synchronous lesions, can offer some additional help to endoscopists when determining surveillance intervals in patients with serrated polyps. In addition, observed association between SSA/P with advanced conventional neoplasia (but not low-grade adenomas) suggests 2 distinct groups of patient predisposition, one with both advanced conventional and important serrated precursors (SSA/P) and the other largely restricted to nonadvanced conventional adenomas and HPs only. Whether the association reported here has to do with SSA/P diagnosis per se or generally larger size of SSA/P remains to be determined in future studies.


Subject(s)
Adenomatous Polyps/pathology , Cell Proliferation , Colonic Polyps/pathology , Neoplasms, Multiple Primary/pathology , Adenomatous Polyps/classification , Aged , Biopsy , Colonic Polyps/classification , Colonoscopy , Female , Humans , Hyperplasia , Male , Middle Aged , Neoplasms, Multiple Primary/classification , Observer Variation , Predictive Value of Tests , Reproducibility of Results , Retrospective Studies , Tumor Burden
17.
Pancreatology ; 17(2): 263-266, 2017.
Article in English | MEDLINE | ID: mdl-28215485

ABSTRACT

OBJECTIVES: Concurrent intraductal papillary-mucinous neoplasm (IPMN) and autoimmune pancreatitis (AIP) was observed in a patient (index case) at our institution. Cases of coincidental IPMN and type 1 AIP and concurrent ductal adenocarcinoma (PDAC) and AIP have been previously reported. In this study we evaluate the hypothesis that IPMN elicits an IgG4 response. METHODS: Twenty-one pancreases (including the index case) with IPMN resected at our institution were studied. H&E stained slides were reviewed and blocks of peritumoral pancreas were immunostained with IgG4 to look for IgG4-positive plasma cells. RESULTS: We found evidence of variable IgG4 overexpression in 4/21 (19%) of IPMN. These included the index case and three others without stigmata of AIP. CONCLUSION: A small subset of pancreatic neoplasms including intraductal papillary-mucinous neoplasms (IPMN) is associated with an IgG4 autoimmune response that sometimes progresses to peritumoral type 1 AIP and less often to diffuse AIP and IgG4-related systemic disease.


Subject(s)
Adenocarcinoma, Mucinous/pathology , Autoimmune Diseases/immunology , Carcinoma, Pancreatic Ductal/pathology , Carcinoma, Papillary/pathology , Immunoglobulin G/blood , Pancreatitis/immunology , Adenocarcinoma, Mucinous/complications , Adenocarcinoma, Mucinous/immunology , Autoimmune Diseases/pathology , Carcinoma, Pancreatic Ductal/complications , Carcinoma, Pancreatic Ductal/immunology , Carcinoma, Papillary/complications , Carcinoma, Papillary/immunology , Humans , Male , Middle Aged , Pancreatitis/complications , Pancreatitis/pathology
18.
Am J Gastroenterol ; 112(7): 1209, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28071660

ABSTRACT

This corrects the article DOI: 10.1038/ajg.2016.368.

19.
Arch Pathol Lab Med ; 141(1): 125-130, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27681330

ABSTRACT

CONTEXT: -Evaluation of 12 or more lymph nodes (LNs) is currently used as a quality indicator for adequacy of pathologic examination of colon cancer resections. OBJECTIVE: -To evaluate the utility of a focused LN search in the immediate vicinity of the tumor and a "second look" protocol in improving LN staging in colon cancer. DESIGN: -Lymph nodes were submitted separately from the primary nodal basin (PNB) and secondary nodal basin (SNB) defined as an area less than 5 cm away and an area greater than 5 cm away from the tumor edge, respectively, in 201 consecutive resections (2010-2013). One hundred sixty-eight consecutive tumors (2006-2009) were used as a control group. A second search was performed in all cases that were N0 after the first search. RESULTS: -In cases that were N0 after the first search, 20.9 ± 10.8 LNs were collected from the PNB, compared to 8.5 ± 9.1 from the SNB. Positive LNs were found in N+ tumors in the PNB in all cases but in only 9% (4 of 46) of SNBs (P < .001). A second search increased node count by an average of 10 additional LNs. In 5 of 114 cases (4.4%), N0 after the first search converted to N+ after a second search that yielded 1 to 4 positive LNs, all of which were in the PNB. CONCLUSIONS: -Emphasis on the number of LNs examined from the PNB and a "second look" protocol improve nodal staging.


Subject(s)
Adenocarcinoma/pathology , Colon/pathology , Colonic Neoplasms/pathology , Lymph Nodes/pathology , Aged , Aged, 80 and over , Health Status Indicators , Humans , Lymph Node Excision , Lymphatic Metastasis , Middle Aged , Neoplasm Staging , Pathology, Clinical/methods , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...